The smoke-free tobacco showdown recently exploded due to the addition of one more competitor. The pharmaceutical giant GSK (Glaxo Smith-Kline) has loaded their big guns and is aiming precisely for the new orally disintegrating nicotine products made by RJR (R.J. Reynolds). GSK has demanded the FDA require R.J. Reynolds to remove its dissolvable nicotine supplements completely from the market place. Although still in review from the FDA, RJR has launched their orally dispersed nicotine products to test markets around the nation.
The new products available under the labels Camel Strips, Camel Orbs & Camel Sticks “are at present being marketed with out distinctive proof of their health and safety” states a spokesman for GSK. The pharmaceutic company takes issue because of the fact that before GSK had been allowed to release their own nicotine-replacement therapies, they were expected to spend millions of dollars finishing medical studies the FDA said were mandatory due to safety purposes.
GSK questions how RJR was allowed to start offering it’s product although not investing in safety tests. Specifically troubling to GSK is the fact RJR is in fact promoting its product to be a smoking cessation product and a reliable, healthier alternative to smoking.
This controversy with smoke free tobacco products isn’t new. Since 2000 the FDA, together with Local, State and Federal jurisdictions, have been attempting to prevent the selling of products including electronic cigarettes and dissolvable nicotine products. Opponents claim that these smoking substitutes will become a “gateway” product resulting in young children along with non-smokers to frequently start smoking cigarettes. All of the currently available smoking replacement products continue to contain the highly habit forming component nicotine.
GSK calls RJR’s claims that their (blank) product can be used to give up smoking an “untested publicity con”. GSK suggests “there are significant possibilities to enhance the impact of current stop smoking aids, including expanding accessibility to and utilization of NRT techniques.” Put simply, GSK thinks their extensively tested Nicotine replacement therapy approaches should not need to compete with untested and possibly hazardous items like dissolvable tobacco and the e-cig.
Do you want to find the best deals on the e cig? Then visit www.electroniccigaretteinc.net to find the best prices on e-cigs, supplies and pcc kits.